Leukemia Research
Volume 34, Issue 1 , Pages 18-23 , January 2010

Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia

  • Yung-Li Yang

      Affiliations

    • Department of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Shu-Rung Lin

      Affiliations

    • Department of Bioscience Technology, College of Science, Chung-Yuan Christian University, Taoyuan, Taiwan
    • ,
  • Jiann-Shiuh Chen

      Affiliations

    • Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Shu-Wha Lin

      Affiliations

    • Department of Medical Research, College of Medicine, National Taiwan University, Taipei, Taiwan
    • National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Sung-Liang Yu

      Affiliations

    • Department of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Medical Research, College of Medicine, National Taiwan University, Taipei, Taiwan
    • National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
    • NTU Center for Genomic Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Hsuan-Yu Chen

      Affiliations

    • Institute of Statistical Science Academia Sinica, Taiwan
    • ,
  • Ching-Tzu Yen

      Affiliations

    • National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Chien-Yu Lin

      Affiliations

    • Institute of Statistical Science Academia Sinica, Taiwan
    • ,
  • Jing-Fang Lin

      Affiliations

    • National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Kai-Hsin Lin

      Affiliations

    • Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Shiann-Tarng Jou

      Affiliations

    • Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Chung-Yi Hu

      Affiliations

    • National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Sheng-Kai Chang

      Affiliations

    • National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Meng-Yao Lu

      Affiliations

    • Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Hsiu-Hao Chang

      Affiliations

    • Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Wan-Hui Chang

      Affiliations

    • Taiwan Childhood Cancer Foundation, Taipei, Taiwan
    • ,
  • Kuo-Sin Lin

      Affiliations

    • Taiwan Childhood Cancer Foundation, Taipei, Taiwan
    • ,
  • Dong-Tsamn Lin

      Affiliations

    • Department of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author at: Department of Laboratory Medicine and Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, No. 7 Chung-San S. Rd., Sec. 1, Taipei 100, Taiwan. Tel.: +886 2 23123456x65399; fax: +886 2 23224263.

Received 15 January 2009 ,Revised 12 July 2009 ,Accepted 14 July 2009.

References 

  1. Holleman A, den Boer ML, Kazemier KM, Janka-Schaub GE, Pieters R. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood. 2003;102:4541–4546
  2. Flotho C, Coustan-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood. 2007;110:1271–1277
  3. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–178
  4. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030–1043
  5. Holleman A, den Boer ML, de Menezes RX, et al. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood. 2006;107:769–776
  6. Flotho C, Coustan-Smith E, Pei D, et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood. 2006;108:1050–1057
  7. Choi J, Hwang YK, Sung KW, et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood. 2007;109:471–477
  8. Liang DC, Hung IJ, Yang CP, et al. Unexpected mortality from the use of E. coli l-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group. Leukemia. 1999;13:155–160
  9. Lin WY, Liu HC, Yeh TC, Wang LY, Liang DC. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50:523–527
  10. Yu IS, Lin SR, Huang CC, et al. TXAS-deleted mice exhibit normal thrombopoiesis, defective hemostasis, and resistance to arachidonate-induced death. Blood. 2004;104:135–142
  11. Kataoka T, Holler N, Micheau O, et al. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J Biol Chem. 2001;276:19548–19554
  12. Benedict MA, Hu Y, Inohara N, Nunez G. Expression and functional analysis of Apaf-1 Isoforms. Extra WD-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J Biol Chem. 2000;275:8461–8468
  13. Seol D-W, Billiar TR. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J Biol Chem. 1999;274:2072–2076
  14. Nachmias B, Ashhab Y, Bucholtz V, et al. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res. 2003;63:6340–6349
  15. Moos PJ, Raetz EA, Carlson MA, et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res. 2002;8:3118–3130
  16. Fine BM, Stanulla M, Schrappe M, et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood. 2004;103:1043–1049
  17. Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951–2959
  18. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133–143
  19. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87
  20. Holleman A, Cheok MH, den Boer ML, et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med. 2004;351:533–542
  21. Lugthart S, Cheok MH, den Boer ML, et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell. 2005;7:375–386
  22. Catchpoole D, Guo D, Jiang H, Biesheuvel C. Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: Prognostication or protocol selection?. Blood. 2008;111:2486-a–2487-a
  23. Flotho C, Coustan-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predict treatment outcome in childhood acute lymphoblastic leukemia. Blood. 2007;
  24. Loh ML, Goldwasser MA, Silverman LB, et al. Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood. 2006;107:4508–4513
  25. Rubnitz JE, Wichlan D, Devidas M, et al. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol. 2008;26:2186–2191
  26. Cario G, Stanulla M, Fine BM, et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood. 2005;105:821–826
  27. Chiaretti S, Li X, Gentleman R, et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood. 2004;103:2771–2778

PII: S0145-2126(09)00370-1

doi: 10.1016/j.leukres.2009.07.023

Leukemia Research
Volume 34, Issue 1 , Pages 18-23 , January 2010

Article Tools

* Image Usage & Resolution